Retatrutide is a triple agonist targeting GLP-1, GIP and glucagon receptors, developed for the management of obesity and significant weight reduction. Administered by subcutaneous injection, it combines anorexigenic effects, improved insulin sensitivity and increased energy metabolism. Clinical trials have shown marked weight losses greater than those observed with current treatments, positioning retatrutide as a promising option for the medical management of obesity.
Retatrutide is a triple agonist targeting GLP-1, GIP and glucagon receptors, developed for the management of obesity and significant weight reduction. Administered by subcutaneous injection, it combines anorexigenic effects, improved insulin sensitivity and increased energy metabolism. Clinical trials have shown marked weight losses greater than those observed with current treatments, positioning retatrutide as a promising option for the medical management of obesity.
Tessamorelin is a growth hormone-releasing peptide specifically targeting the reduction of abdominal fat in individuals with excess body fat, particularly those living with HIV. By stimulating the secretion of growth hormone, this peptide promotes lipolysis, enabling a decrease in visceral fat while improving body composition. Primarily used in medical contexts, Tessamorelin is also being explored for its potential benefits on metabolic health and aging.
⚠️Important note
Each product must be mixed with bacteriostatic water. A Free 3ml bottle is included with every purchase.
Tirzepatide 30mg is a prescription medication that acts on both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. FDA-approved tirzepatide products are used for specific medical indications, including improving blood sugar control in adults with type 2 diabetes and, under the appropriate FDA-approved product, chronic weight management in eligible adults. It works by influencing glucose-dependent insulin secretion, appetite, and energy intake.
Tirzepatide 30mg is a prescription medication that acts on both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. FDA-approved tirzepatide products are used for specific medical indications, including improving blood sugar control in adults with type 2 diabetes and, under the appropriate FDA-approved product, chronic weight management in eligible adults. It works by influencing glucose-dependent insulin secretion, appetite, and energy intake.
